Wednesday, February 8, 2017

Big Pharma: The Business of Healthcare

There has been a lot of recent news highlighting the ethical dilemma associated with big pharmaceutical companies. The recent big scandal included the epi-pen price hike which left thousands of Americans not able to afford a medication needed in a critical situation. Do big pharmaceutical companies have the right to capitalize on life-saving drugs? This is one of the biggest questions we face in the healthcare system today.

We have to keep in mind that pharmaceutical companies are big corporations that are out to make a profit, but at what price? We understand that in order to create new potentially life-saving drugs, money, time and resources have to be put into the process of drug discovery. When a new drug comes out on a patent the drug companies are able to profit from this drug for years. They are able to control the market, set prices, and negotiate with wholesalers. This can prevent patients from getting the access with a hefty price.

This type of monopoly of drug prices can be controlled. Having universal healthcare controlled by legislation can negotiate fair prices for drugs and set caps on the pharmaceutical companies. European countries have had this model to control drug prices for years. Universal healthcare provides the access to health care providers, drugs, and services to those who previously did not have access. Universal healthcare can be the solution to fair and equal access for all Americans while controlling the drug market.

An Industry Divided

The pharmaceutical industry is just that: an industry.  Along with drug discovery and development, those in pharma are also responsible for business aspects such as marketing, finance, and competition with other pharmaceutical organizations.  While pharma has a bad reputation for being corrupt, my opinion is that the industry as a whole is not corrupt, but its members who have impure intentions may be.

Drug discovery and development are essential for disease management as we know it today.  With the high prevalence of many chronic disorders, the continuing survival of bacterial and viral infections, and the emergence of new illnesses and disease states, many people are dependent on the pharmaceutical industry constantly researching and developing treatments to maintain their health and quality of life.  I believe that the professionals who are dedicated to research, drug development, and drug discovery truly do have the best interests in mind for patients.  Therefore, I fully support the efforts of these individuals, and although this side of pharma can come at high costs, this is what is necessary to develop appropriate, efficacious drugs to improve overall health outcomes.  Another related issue that I am not sure how I feel about yet is the outsourcing of manufacturing and development of drugs to other countries (and to be frank, I don't really know a lot about this so if one of you could enlighten me that would be great!).

However, I believe that some departments in the pharmaceutical industry are not fully committed to patient care and health improvement, and may have other intentions that tend to be selfish or corrupt. For instance, the business and finance side of pharma requires that the companies are able to be financially stable and competitive across the industry.  This may cause them to raise drug prices or make other business decisions that negatively impact patient access to the drugs or other aspects of the patient care intent to drug development.  Additionally, there are always people whose greed overrides their sense of humanity, and these are the people whose actions reflect most poorly on the pharmaceutical industry.  For instance, Martin Shkreli of Turing and Heather Bresch of Mylan were two CEOs whose decisions caused their drugs to be astronomically overpriced and unavailable to patients.  As high-up members of the business side, these two did not have the direct responsibility of drug research, development, or patient care, and thus did not concern themselves with the health-related consequences of their decisions.  In this regard, I believe that the pharmaceutical industry could be improved greatly to prevent attempts at unnecessarily maximizing profit at the expense of patient care.

Big Pharma, more like Big Fraud-a

As you can tell by my title, I am not a huge fan of big pharma. This is an industry that could change the world and they just fall short in a lot of areas. Big pharma is great at making big profits, but just sufficient at developing medications to treat the world's problems. I understand that it is not their job to be altruistic and seek cures for diseases, but I don't respect the industry because they operate almost solely on a for-profit bases in the United States. Commonly, big pharma spends resources developing medications that are combination drugs or drugs in the same classes of drugs that already exist treating diseases that already have medications to treat that problem. These companies could be using their talent and resources to seek cures for diseases that are devastating the world, instead of finding maintenance treatments that over the long-run will be quite lucrative for these companies. It's all about the money though. I can't fault them, since they live and operate in a capitalistic society, but in the year 2017, I would like to think that companies that have the power to change the world for the better have a duty to do so. As Ben Parker once said, "with great power comes great responsibility."